Literature DB >> 25542251

Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.

Iro Karagiorga1, George A Partsinevelos, Despina Mavrogianni, Elli Anagnostou, Ioannis Zervomanolakis, Konstantinos Kallianidis, Petros Drakakis, Dimitris Loutradis.   

Abstract

PURPOSE: The aim of the study was to evaluate whether the presence Antimullerian hormone (AMH) and Antimullerian hormone type II receptor (AMHRII) single nucleotide polymorphisms (SNPs) Ile(49)Ser and -482A>G respectively are related to the assisted reproduction outcome.
METHODS: A prospective cross-sectional observational study was conducted in order to assess the distribution of AMH and AMHRII SNPs in two cohorts, one of healthy women (N = 100) and the control group and the IVF/ICSI group (N = 151) consisted of women undergoing IVF/ICSI treatment for infertility. Furthermore, a prospective longitudinal observational study was performed on the latter group to assess possible associations of these SNPs with patients' characteristics and controlled ovarian stimulation (COS) and pregnancy outcome.
RESULTS: Among non-carriers of the AMH (Ile(49)Ser) polymorphism, basal FSH levels were lower in those with more than two of previous IVF attempts and fertilization rate was statistically higher in those with peak serum E2 levels below 1500 pg/ml, whereas among non-carriers of the AMHRII (-482 A>G) polymorphism, number of follicles was higher in those with more than two previous IVF attempts and total dose of gonadotropins was lower in those with peak serum E2 levels above 1500 pg/ml.
CONCLUSIONS: There was evidence that in specific subgroups of women undergoing IVF/ICSI, AMH and AMHRII SNPs may be related to patients' characteristics and controlled ovarian stimulation and pregnancy outcome and thus may provide a means for the prediction of ovarian response in specific subgroups of women entering an IVF/ICSI program.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25542251      PMCID: PMC4363245          DOI: 10.1007/s10815-014-0403-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  43 in total

1.  Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.

Authors:  David H Barad; Andrea Weghofer; Norbert Gleicher
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

2.  Infertility Part I: Pathophysiology and diagnosis.

Authors:  T Burns
Journal:  Ariz Med       Date:  1977-03

3.  Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary.

Authors:  A L Durlinger; P Kramer; B Karels; F H de Jong; J T Uilenbroek; J A Grootegoed; A P Themmen
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

4.  Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.

Authors:  Marlies E Kevenaar; Axel P N Themmen; Joop S E Laven; Barbara Sonntag; Sharon Lie Fong; André G Uitterlinden; Frank H de Jong; Huibert A P Pols; Manuela Simoni; Jenny A Visser
Journal:  Hum Reprod       Date:  2007-03-02       Impact factor: 6.918

Review 5.  AMH/MIS: what we know already about the gene, the protein and its regulation.

Authors:  Rodolfo Rey; Céline Lukas-Croisier; Celina Lasala; Patricia Bedecarrás
Journal:  Mol Cell Endocrinol       Date:  2003-12-15       Impact factor: 4.102

6.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

Review 7.  Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

Authors:  A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe
Journal:  Hum Reprod Update       Date:  2009-09-30       Impact factor: 15.610

Review 8.  Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction.

Authors:  M Simoni; E Nieschlag; J Gromoll
Journal:  Hum Reprod Update       Date:  2002 Sep-Oct       Impact factor: 15.610

9.  Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation.

Authors:  Mohammad Hasan Sheikhha; Maryam Eftekhar; Seyed Mehdi Kalantar
Journal:  J Hum Reprod Sci       Date:  2011-05

Review 10.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

View more
  8 in total

1.  Can polymorphisms of AMH/AMHR2 affect ovarian stimulation outcomes? A systematic review and meta-analysis.

Authors:  Di Chen; Xiangyu Zhu; Jielei Wu
Journal:  J Ovarian Res       Date:  2020-09-04       Impact factor: 4.234

2.  Association of AMH and AMHR2 gene polymorphisms with ovarian response and pregnancy outcomes in Indian women.

Authors:  Stacy Colaco; Swati Achrekar; Akshata Patil; Unnati Sawant; Sadhna Desai; Vijay Mangoli; Padma Rekha Jirge; Deepak Modi; Smita D Mahale
Journal:  J Assist Reprod Genet       Date:  2022-06-17       Impact factor: 3.357

3.  An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.

Authors:  B S Eisele; G C Villalba Silva; C Bessow; R Donato; V K Genro; J S Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2021-03-31       Impact factor: 3.357

4.  Comparison of the Fetal Fraction of Cell-Free DNA in In-Vitro Fertilization (IVF) Versus Natural Conception Evaluation of the Fetal Fraction With IVF Parameters.

Authors:  Kostas Kallianidis; Evangelia Dimitroulia; Depy Mavrogianni; Emmanuaela Liokari; Ritsa Bletsa; Elli Anagnostou; Nikos Sofikitis; Dimitrios Loutradis
Journal:  Cureus       Date:  2022-04-26

5.  Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles.

Authors:  Cheng-Hsuan Wu; Shun-Fa Yang; Hui-Mei Tsao; Yu-Jun Chang; Tsung-Hsien Lee; Maw-Sheng Lee
Journal:  Int J Environ Res Public Health       Date:  2019-03-08       Impact factor: 3.390

6.  Association of two single nucleotide polymorphisms rs10407022 and rs3741664 with the risk of primary ovarian insufficiency in a sample of Iraqi women.

Authors:  Tamadher Abbas Rafaa; Ahmed AbdulJabbar Suleiman; Mustafa Falah Dawood; Ali Mohammed Al-Rawi
Journal:  Mol Biol Res Commun       Date:  2020-12

7.  AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.

Authors:  Christian Cerra; William G Newman; Dalia Tohlob; Helen Byers; Gregory Horne; Stephen A Roberts; Lamiya Mohiyiddeen
Journal:  J Assist Reprod Genet       Date:  2016-05-03       Impact factor: 3.412

8.  The Role of FSHR SNPs and AMH in Follicular Fluid and Serum in Ovarian Response during COS: A Pilot Study.

Authors:  Elli Anagnostou; Despina Mavrogianni; Ilectra-Niki Prifti; Evangelia Dimitroulia; Athanasios Protopapas; Peter Drakakis; Dimitrios Loutradis
Journal:  Int J Reprod Med       Date:  2021-02-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.